Long-Term Growth Outlook for the iPS Drug Discovery and Regenerative Medicine Markets
First written in FY2023. 2 of 3 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025RestatedAnnual report
「The global market contributed by iPS drug discovery in psychiatric and neurological diseases is forecast to reach ¥6.1 trillion in 2040. The regenerative medicine market is forecast to reach ¥2.5 trillion in Japan and ¥38 trillion globally by 2050.」
The company reiterates market-size forecasts for iPS drug discovery and regenerative medicine for 2040 and 2050. - FY2024RestatedAnnual report
「The global market contributed by iPS drug discovery in psychiatric and neurological diseases is forecast to reach ¥6.1 trillion in 2040. The regenerative medicine market is forecast to reach ¥2.5 trillion in Japan and ¥38 trillion globally by 2050.」
The company reiterates long-term market-size forecasts for iPS drug discovery and regenerative medicine as part of the business environment. - FY2023First statedAnnual report
「The global market contributed by iPS drug discovery in psychiatric and neurological diseases is forecast to reach ¥6.1 trillion in 2040. The regenerative medicine market is forecast to reach ¥2.5 trillion in Japan and ¥38 trillion globally by 2050.」
The company presents 2040 and 2050 market-size forecasts for iPS drug discovery and regenerative medicine as part of the business environment.